1-10 of 10
S Slordahl
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Selinexor with Alternating Bortezomib or Lenalidomide Plus Dexamethasone in Transplant Ineligible Newly Diagnosed Multiple Myeloma Patients (SABLe), Nordic Myeloma Study Group 29/21

Ida Bruun Bruun Kristensen, Hanne Marie Norseth, Diana Loigom, Henrik Gregersen, Einar Haukås, Tobias S. S. Slørdahl, Robert Schou Pedersen, Damian L. Szatkowski, Fredrik Schjesvold, Thomas Lund
Journal: Blood
Blood (2024) 144 (Supplement 1): 1988.
https://doi.org/10.1182/blood-2024-194840
Published: 2024
Journal Articles

A Phase II Study Measuring MRD Negativity after Bispecific T-Cell Redirectors Talquetamab and Teclistamab Consolidation Used in Sequence As Part of First Line Treatment in Transplant Eligible Multiple Myeloma Patients (TALTEC), Nordic Myeloma Study Group

Diana Loigom, Tobias S. S. Slørdahl, Anna Lysén, Agoston Gyula Szabo, Tine Rosenberg, Lene Kongsgaard Nielsen, Jakub Krejcik, Anne Marit Sponaas, Kristine Misund, Nicolai Jacob Wewer Albrechtsen, Jakob Nordberg Nørgaard, Thomas Lund, Sarah Leeth Hansen Farmer, Einar Haukås, Kari Lenita Falck Moore, Tatjana Tratš, Claire Albrecht, Diptendu Santra, Pavel Smirnov, Margaret Doyle, Kathleen S Gray, Fredrik Schjesvold
Journal: Blood
Blood (2024) 144 (Supplement 1): 7016.
https://doi.org/10.1182/blood-2024-203364
Published: 2024
Journal Articles

Replacing Steroids in Transplant-Ineligible Multiple Myeloma: The Phase 2 Isatuximab-Bortezomib-Lenalidomide-Dexamethasone Rest Study

Frida Bugge Bugge Askeland, Einar Haukås, Tobias S. S. Slørdahl, Anja Klostergaard, Tatjana Alexandersen, Anna Lysén, Pegah Abdollahi, Emil Hermansen, Fredrik Schjesvold
Journal: Blood
Blood (2024) 144 (Supplement 1): 4730.
https://doi.org/10.1182/blood-2024-193864
Published: 2024
Journal Articles

Replacing Steroids in Transplant-Ineligible Multiple Myeloma: The Phase 2 Isatuximab-Bortezomib-Lenalidomide-Dexamethasone Rest Study

Frida Bugge Askeland, Einar Haukås, Tobias S. Slørdahl, Anja Klostergaard, Tatjana Alexandersen, Diana Schjøll, Anna Lysen, Emil Hermansen, Fredrik Schjesvold
Journal: Blood
Blood (2023) 142 (Supplement 1): 3381.
https://doi.org/10.1182/blood-2023-173126
Published: 2023
Journal Articles

Will Survival Improve By Treating Multiple Myeloma Patients at MRD Relapse? the Remnant Study

Frida Bugge Askeland, Anne-Marie Rasmussen, Anna Lysen, Einar Haukås, Anette Løken Eilertsen, Magnus Moksnes, Galina Tsykunova, Anders Vik, Birgitte Dahl Eiken, Vidar Stavseth, Jürgen Rolke, Eivind Ottersen Samstad, Valdas Peceliunas, Randi Fykse Hallstensen, Ariane Aasbø Hansen, Anita Smith Nilsen, Tobias S. Slørdahl, Fredrik Schjesvold
Journal: Blood
Blood (2023) 142 (Supplement 1): 4755.
https://doi.org/10.1182/blood-2023-189022
Published: 2023
Journal Articles

Replacing Steroids in Transplant-Ineligible Multiple Myeloma: The Phase 2 Isatuximab-Bortezomib-Lenalidomide-Dexamethasone Rest Study

Frida Bugge Bugge Askeland, Einar Haukås, Tobias S. Slørdahl, Diana Schjøll, Anna Lysén, Emil Hermansen, Fredrik Schjesvold
Journal: Blood
Blood (2022) 140 (Supplement 1): 12623–12625.
https://doi.org/10.1182/blood-2022-156625
Published: 2022
Journal Articles

Monoclonal immunoglobulins promote bone loss in multiple myeloma

Marita Westhrin, Vlado Kovcic, Zejian Zhang, Siv H. Moen, Tonje Marie Vikene Nedal, Albert Bondt, Stephanie Holst, Kristine Misund, Glenn Buene, Anders Sundan, Anders Waage, Tobias S. Slørdahl, Manfred Wuhrer, Therese Standal
Journal: Blood
Blood (2020) 136 (23): 2656–2666.
https://doi.org/10.1182/blood.2020006045
Published: 2020
Includes: Supplemental data
Journal Articles

The Serine Protease Matriptase Acts As a Tumour Suppressor in Multiple Myeloma

Ida Steiro, Pegah Abdollahi, PhD, Magne Børset, MD PhD, Tobias S. Slørdahl, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 14.
https://doi.org/10.1182/blood-2020-140229
Published: 2020
Journal Articles

Glycosylationof Immunoglobulins Determine Bone Loss in Multiple Myeloma

Marita Westhrin, Vlado Kovcic, Albert Bondt, Stephanie Holst, Zejian Zhang, Anders Sundan, PhD, Tobias S. Slørdahl, Anders Waage, MD PhD, Manfred Wuhrer, Therese Standal
Journal: Blood
Blood (2019) 134 (Supplement_1): 4324.
https://doi.org/10.1182/blood-2019-122542
Published: 2019
Journal Articles

T-cell receptor tau delta +/CD3+4-8-T- cell acute lymphoblastic leukemias: a distinct subgroup of leukemias in children. A report of five cases

GC Alfsen, K Beiske, H Holte, E Hovig, A Deggerdal, I Sandlie, E Widing, S Slordahl, LK Klepper, W Sizoo
Journal: Blood
Blood (1991) 77 (9): 2023–2030.
https://doi.org/10.1182/blood.V77.9.2023.2023
Published: 1991